BioMed Research International / 2013 / Article / Fig 2

Research Article

Off-Label Use of Ondansetron in Pregnancy in Western Australia

Figure 2

Dispensing patterns of ondansetron from three-months before pregnancy until delivery, to the 12 women with a child with a birth defect.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.